当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析 - 现金流量表

立方制药

(003020)

  

流通市值:36.79亿  总市值:50.80亿
流通股本:1.38亿   总股本:1.90亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,219,554,435.8886,897,488.23406,963,122.741,548,621,716.57
  收到的税费返还18,754,208.6520,726113,292.461,151,676.5
  收到其他与经营活动有关的现金62,164,969.8633,806,088.6123,614,457.1844,481,206.32
  经营活动现金流入小计1,300,473,614.31920,724,302.84430,690,872.381,594,254,599.39
  购买商品、接受劳务支付的现金383,767,579.62320,484,856.11139,979,682.17369,357,669.69
  支付给职工以及为职工支付的现金158,566,262.36111,763,195.665,853,534.83190,909,549.74
  支付的各项税费129,451,331.1188,496,714.3639,645,112.84172,960,048.76
  支付其他与经营活动有关的现金440,664,691.96303,377,068.78149,151,329.23663,494,588.43
  经营活动现金流出小计1,112,449,865.05824,121,834.85394,629,659.071,396,721,856.62
  经营活动产生的现金流量净额188,023,749.2696,602,467.9936,061,213.31197,532,742.77
二、投资活动产生的现金流量:
  收回投资收到的现金598,377,416.01218,377,416.0155,000,000375,000,000
  取得投资收益收到的现金23,201,455.2422,171,581.682,917,754.725,891,942.85
  处置固定资产、无形资产和其他长期资产收回的现金净额1,721,995.4175,213.142,000492,272.8
  收到的其他与投资活动有关的现金25,300---
  投资活动现金流入小计623,326,166.66240,624,210.8357,919,754.72381,384,215.65
  购建固定资产、无形资产和其他长期资产支付的现金91,122,899.6265,219,814.8835,088,231.6154,486,796.04
  投资支付的现金611,860,000331,860,00041,860,000384,652,054.79
  取得子公司及其他营业单位支付的现金---24,480,000
  投资活动现金流出小计702,982,899.62397,079,814.8876,948,231.6563,618,850.83
  投资活动产生的现金流量净额-79,656,732.96-156,455,604.05-19,028,476.88-182,234,635.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金---100,000
  其中:子公司吸收少数股东投资收到的现金---100,000
  取得借款收到的现金---28,600,000
  收到其他与筹资活动有关的现金086,4951,0001,115,754.3
  筹资活动现金流入小计086,4951,00029,815,754.3
  分配股利、利润或偿付利息支付的现金125,760,565.92117,509,325.9238,252,10096,613,353.27
  其中:子公司支付给少数股东的股利、利润---15,680,000
  支付其他与筹资活动有关的现金19,706,198.5211,753,465.164,187,617.411,534,146.73
  筹资活动现金流出小计145,466,764.44129,262,791.0842,439,717.4108,147,500
  筹资活动产生的现金流量净额-145,466,764.44-129,176,296.08-42,438,717.4-78,331,745.7
四、汇率变动对现金及现金等价物的影响-23,824.49-7,247-1,133.255,484.88
五、现金及现金等价物净增加额-37,123,572.63-189,036,679.14-25,407,114.22-63,028,153.23
  加:期初现金及现金等价物余额439,694,059.59439,694,059.59436,891,607.84502,722,212.82
  期末现金及现金等价物余额402,570,486.96250,657,380.45411,484,493.62439,694,059.59
补充资料:
  净利润-91,530,260.09-152,480,813.62
  资产减值准备-9,495,304.44-15,872,377.92
  固定资产和投资性房地产折旧-36,557,769.15-66,094,431.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,557,769.15-66,094,431.36
  无形资产摊销-4,864,039.72-9,392,912.65
  长期待摊费用摊销-1,396,784.57-2,762,276.78
  处置固定资产、无形资产和其他长期资产的损失--1,769.91--20,097.78
  固定资产报废损失-1,372.76-4,719,722.95
  公允价值变动损失--141,882.36--1,601,131.58
  财务费用-1,408,492.45-1,914,963.84
  投资损失--26,123,630.38--11,401,826.54
  递延所得税--1,472,539.33--2,881,741.93
  其中:递延所得税资产减少--670,210.24-1,621,383.39
    递延所得税负债增加--802,329.09--4,503,125.32
  存货的减少--46,901,989.09-13,553,921.55
  经营性应收项目的减少-10,044,178.23--133,755,118.31
  经营性应付项目的增加-11,739,322.91-68,916,946.76
  其他-482,954.53-3,239,430.09
  融资租入固定资产---10,399,309.93
  现金的期末余额-250,657,380.45-439,694,059.59
  减:现金的期初余额-439,694,059.59-502,722,212.82
  现金及现金等价物的净增加额--189,036,679.14--63,028,153.23
公告日期2025-10-302025-08-262025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑